Cost Insurance

GLP-1 Savings Programs That Actually Work in 2026

If you've been prescribed a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, you already know the sticker shock. These medications can run $900 to $1,500 per month without insurance coverage. And even with insurance, many plans still don't cover GLP-1s for weight loss, leaving you with the full bill.

The good news? You have options. Between manufacturer savings programs, patient assistance initiatives, and emerging affordable alternatives, more people are finding ways to access these medications without breaking the bank. Let's walk through what actually works.

Understanding GLP-1 Medication Costs

Before we dive into savings programs, it's helpful to understand why these medications are so expensive in the first place.

Brand-name GLP-1 medications are relatively new, still under patent protection, and manufactured by just a handful of pharmaceutical companies. Novo Nordisk makes Ozempic and Wegovy (semaglutide), while Eli Lilly produces Mounjaro and Zepbound (tirzepatide).

Without any discounts or insurance coverage, here's what you're looking at:

These prices reflect the retail cost at most pharmacies. But you don't necessarily have to pay full price.

Manufacturer Savings Programs

Both Novo Nordisk and Eli Lilly offer savings cards and patient assistance programs. These can significantly reduce your out-of-pocket costs, but they come with specific eligibility requirements.

Novo Nordisk Savings Options

For Ozempic and Wegovy, Novo Nordisk offers savings cards that can reduce your monthly cost to as low as $25 if you have commercial insurance. The catch? Your insurance must cover the medication, even if only partially, and you can't be on Medicare, Medicaid, or any government insurance program.

If you don't have insurance at all, Novo Nordisk's patient assistance program may provide free medication if you meet income requirements, typically around 400% of the federal poverty level.

Eli Lilly Savings Card

Lilly's savings card works similarly for Mounjaro and Zepbound. With commercial insurance that covers the medication, you might pay as little as $25 per month. For those paying cash without insurance, Lilly offers a different savings card that caps costs at $550 per month, still a significant discount from retail pricing.

Like Novo Nordisk, Eli Lilly also has a patient assistance program for qualifying individuals without insurance coverage.

Why These Programs May Not Work for You

Here's the reality: most people can't actually use these manufacturer savings programs.

If you're on Medicare, you're automatically excluded. Federal law prohibits Medicare recipients from using manufacturer coupons. This affects millions of Americans, particularly those over 65.

If your insurance doesn't cover GLP-1 medications for weight loss at all, the savings cards won't help. The medication needs to be on your plan's formulary, even if your share of the cost is high.

And if you're uninsured, while patient assistance programs exist, the application process can be lengthy and income requirements may disqualify many middle-income individuals.

A Note on Gender Differences

Women are more likely to seek GLP-1 medications for weight management, partly due to hormonal factors that can make weight loss more challenging, especially during perimenopause and menopause. Unfortunately, insurance companies often apply the same coverage restrictions regardless of these biological differences. If you're navigating menopause-related weight gain, the lack of insurance coverage can feel particularly frustrating.

Independent Pharmacy Discount Programs

Don't overlook traditional pharmacy discount cards. Programs like GoodRx, SingleCare, and RxSaver can sometimes offer better prices than your insurance copay.

That said, discounts on brand-name GLP-1s through these services typically only bring the cost down to $800-$900 per month, still out of reach for most people. These cards work best when combined with other strategies or for short-term use.

The Compounded GLP-1 Alternative

This is where things get more accessible. Compounded versions of semaglutide and tirzepatide offer the same active ingredients as brand-name medications but at a fraction of the cost.

Compounding pharmacies can legally produce these medications when the brand-name versions are on the FDA's drug shortage list, which has been the case for most GLP-1 medications over the past year.

Compounded GLP-1s typically cost between $99 and $400 per month, making them dramatically more affordable than brand-name options. They're prescribed by licensed physicians and shipped directly to your home from certified compounding pharmacies.

Is Compounded the Same as Brand-Name?

Compounded medications use the same active ingredient (semaglutide or tirzepatide) but aren't FDA-approved in the same way brand-name drugs are. They're made to order by licensed pharmacies following strict quality standards.

For many people, especially those who can't afford brand-name options or don't have insurance coverage, compounded GLP-1s provide a legitimate and effective pathway to treatment.

Questions to Ask Before Starting Any Savings Program

Before committing to any savings program or alternative, have these conversations with your healthcare provider:

Your doctor should be a partner in finding an affordable path forward, not just writing a prescription and hoping you figure out the rest.

From the Ozari Care Team

The most important savings strategy is consistency. We see patients who stop and start GLP-1 therapy due to cost, which can reduce effectiveness and make side effects worse when restarting. Finding a price point you can sustain for at least 6-12 months leads to better outcomes than cycling on and off based on monthly budget fluctuations.

Making GLP-1 Therapy Affordable

At Ozari Health, we offer compounded Semaglutide and Tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026